Martin Auster | executive |
Raju Mohan | executive |
Liam Hiester | analyst |
Emily Bodnar | analyst |
Gospel Enyindah-Asonye | analyst |
Alexander Thompson | analyst |
Derek Archila | analyst |
Samuel Slutsky | analyst |
Good afternoon, ladies and gentlemen, and welcome to the Ventyx Biosciences First Quarter 2024 Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded.
I would now like to turn the call over to Dr. Martin Auster, Ventyx' Chief Financial Officer. Please begin.